Rexulti® Compulsive Behavior Lawsuit

Rexulti® (brexpiprazole) is highly similar to Abilify®, another antipsychotic drug from Otsuka Pharmaceuticals that is linked to gambling addiction and other compulsive behavior disorders.

Have you experienced compulsive behaviors as a result of taking Rexulti? If so, take advantage of a free consultation with our expert drug injury lawyers to learn more about your legal rights. Get the help you deserve – call (877) 562-0000 or fill out our free initial consultation form.

What is Rexulti®?

Rexulti is a prescription drug used to treat mental illnesses such as depression, bipolar disorder, schizophrenia, and Tourette syndrome. It was approved by the U.S. Food & Drug Administration (FDA) on July 10, 2015. Recent reports have linked the drug with compulsive behaviors in patients, including pathological gambling and hypersexual activity. Cory Watson Attorneys is currently investigating Rexulti cases and its potential undisclosed side effects in all 50 states.

Is Rexulti® the Same as Abilify®?

Rexulti and Abilify are highly similar medications. They are both used to treat severe mood disorders like depression and schizophrenia. They are also made by the same manufacturer.

Rexulti manipulates dopamine levels in the brain. Just like in Abilify, the over-stimulation of these levels can lead to uncontrollable and compulsive behaviors such as:

  • Gambling
  • Shopping
  • Sexual behaviors
  • Eating

FDA Warns of Rexulti® Link to Compulsive Behaviors

In February 2018, the FDA issued a drug safety warning for Rexulti, reporting that patients can experience intense urges to gamble while taking the medication. This includes the potential risk of compulsive or uncontrollable urges to binge eat, shop, and have sex. These compulsive behaviors can have devastating effects on patients and their loved ones, including:

  • Personal debt
  • Bankruptcy
  • Home foreclosure
  • Divorce
  • Unemployment
  • Emotional trauma
  • Damaged reputation

According to the FDA, most patients who experience Rexulti impulse control problems have no history of compulsive behavior before taking the drug, and their uncontrollable urges usually stop within days or weeks of reducing Rexulti dosage or after discontinuing its use.

What You Can Do & How We Can Help

Cory Watson Attorneys is heavily involved in Abilify® and Rexulti® litigation, with attorneys appointed by the MDL Judge to help serve in leadership on Abilify lawsuits. We have extensive experience holding drug manufacturers accountable for their negligence and wrongdoing.

If you or someone you know has been injured by Rexulti, you may be entitled to compensation. Contact our drug injury lawyers now to get the help you deserve. Call 24/7 at (877) 562-0000 or fill out our free initial consultation form online. Don’t wait to reach out – contact us today!


Rexulti® is a registered trademark of Lundbeck and Otsuka America Pharmaceutical, and is used here only to identify the product in question. Abilify® is a registered trademark of Bristol-Myers Squibb and Otsuka America Pharmaceutical and is used here only to identify the product in question.

This law firm is not associated with, sponsored by, or affiliated with Otsuka Pharmaceutical Co., Ltd.; Lundbeck; Bristol-Myers Squibb; or the U.S. Food and Drug Administration.